Conclusions

Now is the time to move beyond misconduct as an academic subject and devote more attention to incorporating better clinical research practices to identify and prevent research fraud.These practices include a partnership of the clinical investigator, institutional review board, and the sponsor. Clinical investigators, corporate managers, and individuals alike would do well to re-examine their own practices for warning signs. The failure to adopt a vigorous approach will lead to new cases of research fraud and ultimately erode away public confidence in the research enterprise.

Was this article helpful?

0 0

Post a comment